Alexion is a biopharmaceutical company specializing in the development and commercialization of therapies for rare and ultra-rare diseases. The company focuses on innovative treatments for conditions such as complement-mediated disorders and other serious medical conditions. With a commitment to addressing unmet medical needs, Alexion leverages advanced science and technology to improve patient outcomes and enhance the quality of life for individuals affected by these diseases.